Associated Papers
Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ et al.
Journal of the Neurological Sciences, 2018
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
Yao Z et al.
Nature, 2017
Select a paper to view details